CRVO

CervoMed Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-13

Figures on this page computed 2026-11-08 12:41 UTC

Last close

1.56USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-03-13

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001437749-26-008259
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-13
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001437749-26-008259
Reported in
USD
- 10-K for 2025, filed 2026-03-13
- 10-K for 2025, filed 2026-03-13
- 10-K for 2025, filed 2026-03-13
- 10-Q for 2025, filed 2026-08-07
- 10-K for 2025, filed 2026-03-13
- 10-Q for 2025, filed 2026-08-07
The filing itself
-673.1%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001437749-26-008259
Reported in
USD
- 10-K for 2025, filed 2026-03-13
- 10-K for 2025, filed 2026-03-13
The filing itself
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001437749-26-008259
Reported in
USD
- 10-K for 2025, filed 2026-03-13
- 10-K for 2025, filed 2026-03-13
- 10-K for 2025, filed 2026-03-13
The filing itself
0.00Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001437749-26-008259
Reported in
USD
- 10-K for 2025, filed 2026-03-13
- 10-Q for 2025, filed 2026-08-07
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Growth is the furthest below its sector's middle: 0.21 against 0.46 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

0.77x

1.94x

n/a

0.00x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

4 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-13

Sales0.77x
Its own average over 4 years, 5.2M.
Profit1.94x
Its own average over 10 years, -13.9M.
Free cash flown/a
Its own average over 2 years, -11.8M.
Debt0.00x
Its own average over 5 years, 79.2K.
Price0.00x
Its own average over 11 years, 497. Market data, 2026-11-04

Debt is furthest from its own average, at 0.00 times.

Sales is 0.77 times its own 4-year average; Profit is 1.94 times its own 10-year average; Debt is 0.00 times its own 5-year average; Price is 0.00 times its own 11-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-13

Sales against its own 4-year average0.77
Source
filed
Statement
income
Fiscal year
2025
Accession
0001437749-26-008259
Reported in
USD
The filing itself
Profit against its own 10-year average1.94
Source
filed
Statement
income
Fiscal year
2025
Accession
0001437749-26-008259
Reported in
USD
The filing itself
Free cash flow against its own 2-year averagen/a
Not held.
Source
filed
Statement
income
Fiscal year
2025
Accession
0001437749-26-008259
Reported in
USD
The filing itself
Debt against its own 5-year average0.00
Source
filed
Statement
income
Fiscal year
2025
Accession
0001437749-26-008259
Reported in
USD
The filing itself
Price against its own 11-year average0.003Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD